Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Dementia from PPIs: A hypothesis that may have led to gastrointestinal bleeding

Jeffrey Adler, MD, Shawn Shah, MD, Jenna Koliani-Pace, MD, and Corey Siegel, MD
Meds
March 24, 2016
100 Shares
Share
Tweet
Share

Over the past week, while covering the inpatient gastroenterology service, we cared for three patients who were hospitalized with gastrointestinal bleeding who were found to have large, potentially life-threating, stomach ulcers. All three of the patients had abruptly stopped their acid-suppressing proton pump inhibitor (PPI) medication in the preceding 1 to 2 weeks.  With PPIs being a primary therapy for gastroesophageal reflux and ulcer treatment, why would these patients have stopped their PPIs without medical consultation? Unanimously, they had all heard on the news that a new study found that PPIs might cause dementia.

This past month, a recent study in JAMA Neurology by Gomm and colleagues from the German Center for Neurodegenerative Diseases reported that PPI usage among those over the age of 75 may be associated with a risk of dementia. While the study findings showed a statistical association, it is important to understand the limitations of their findings and how interpretation of these results can lead to significant consequences.

The authors were fair in pointing out certain limitations in their study, and an accompanying editorial by Dr. Kuller further highlighted that while the authors’ findings are potentially important, they are unable to draw the conclusion that PPIs cause dementia.  Furthermore, the American Gastroenterological Association (AGA) and other gastrointestinal societies have released statements on how to interpret such a study, and the importance of educating patients on why they are prescribed PPIs and what their risks and benefits may be.  Despite these warnings, patients have stopped taking their PPIs because they are concerned about the chance of developing dementia, and as a result, possibly placing themselves at risk.

The challenge with such a study is that while it may show a statistical association, it does not prove that PPIs cause dementia.  Rather, this type of research is hypothesis generating. To attempt to get at the “right answer” and understand if PPIs cause dementia, researchers would need to study a cohort of elderly patients without dementia over years while exposing half of them to PPIs and the other half to placebo. After continued surveillance, researchers would then have to determine if either group developed dementia at different rates. The aforementioned is much easier said than done, and perhaps impossible.  Essentially, we have an untestable hypothesis. And therefore, we are left with the challenge of not entirely understanding the validity of the results, and yet scared that our patients, loved ones, and perhaps ourselves, are at risk of harm.

It is easy to fixate on the potential ill-effects of a medication, but it is just as important to take into account the potential harms of the disease they are being used to treat.  PPIs have shown clinical efficacy in the treatment of gastroesophageal reflux disease and its complications (examples include inflammation of the esophagus, and Barrett’s – a precancerous condition), as well as ulcer disease and upper gastrointestinal bleeding.  We also know that abruptly stopping PPIs can lead to rebound hyperacidity, which may very well have contributed to our patient’s ulcer development. Our goal is not to tell people whether they should or should not be taking their PPIs, or to testify about whether the conclusions from the above study are correct.  The issue is that we simply do not know the truth, and for many patients the risk of stopping treatment with a PPI outweighs the risk of developing dementia.

The best advice we can give is in line with the AGAs recommendations to make sure that PPIs are being used appropriately, and if so, to consider the implications of stopping before panicking about long-term unsubstantiated complications. If indeed our three patients this week experienced serious gastrointestinal bleeding because they stopped their PPIs, we are quite certain there are many others out there at risk for harm as well.

Jeffrey Adler, Shawn Shah, Jenna Koliani-Pace, and Corey Siegel are gastroenterologists.

Image credit: Shutterstock.com

Prev

Why doctors kill themselves

March 23, 2016 Kevin 199
…
Next

Naturopaths should be restricted from treating children. Here's why.

March 24, 2016 Kevin 10
…

Tagged as: Gastroenterology

Post navigation

< Previous Post
Why doctors kill themselves
Next Post >
Naturopaths should be restricted from treating children. Here's why.

Related Posts

  • Dementia patients want effective drugs. How will the FDA respond?

    Ron Louie, MD
  • Who says doctors don’t care?

    Cindy Thompson
  • To Paxil, with love

    Jennifer L. Barkin, PhD
  • The FDA was wrong about Aduhelm

    M. Bennet Broner, PhD
  • Who is caring for the care workers?

    Carole A. Estabrooks, PhD and Stephanie Chamberlain
  • Finding a common chord with a patient

    Jimmy Chen

More in Meds

  • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

    Julie Craig, MD
  • The real cause of America’s opioid crisis: Doctors are not to blame

    Richard A. Lawhern, PhD
  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The harmful effects of shaming patients for self-education

      Maryanna Barrett, MD | Physician
    • The power of self-appreciation: Why physicians need to start acknowledging their own contributions

      Wendy Schofer, MD | Physician
    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
    • How this doctor found her passion in ballroom dancing [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Ankle Sprain Physical Therapy Doesn't Shift the Pain Elsewhere
  • Use of EMR Directive Tied to Reduced Opioid Prescribing After Spine Surgery
  • Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosis
  • CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
  • Fla. Doc Charged With Murder; McConnell Exits Rehab Facility; BPA on Store Receipts

Meeting Coverage

  • Ankle Sprain Physical Therapy Doesn't Shift the Pain Elsewhere
  • Use of EMR Directive Tied to Reduced Opioid Prescribing After Spine Surgery
  • CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer
  • CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer
  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
  • Recent Posts

    • The harmful effects of shaming patients for self-education

      Maryanna Barrett, MD | Physician
    • The power of self-appreciation: Why physicians need to start acknowledging their own contributions

      Wendy Schofer, MD | Physician
    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician
    • Telemedicine in the opioid crisis: a game-changer threatened by DEA regulations

      Julie Craig, MD | Meds
    • How this doctor found her passion in ballroom dancing [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Dementia from PPIs: A hypothesis that may have led to gastrointestinal bleeding
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...